Search Results

bacteria produce toxins, such as Bacteroides fragilis toxin and colibactin, that alter CEC signaling and/or damage CEC DNA, resulting in mutations and/or cytotoxicity that further alter host and microbial community function. (C) This multifactorial

to be a time-consuming and daunting task for physicians when they have increasingly less time to spend with patients. This is true in both large academic cancer centers and small community practices. Several studies show the financial

unstructured data, curated via technology-enabled abstraction. 13 The database included data from approximately 280 community and academic cancer clinics (∼800 sites of care) during the study period. Demographic variables for patients in the Flatiron Health

the strategies we implemented to achieve our enrollment goals and engage an underrepresented population in a CCT. Methods Formative Work We developed our study methods and intervention content using community participatory action methods. We

Background: CancerSupportSource (CSS) is a 25-item distress screening tool implemented at community-based cancer support organizations and hospitals nationwide. CSS assesses distress over 5 domains: (1) emotional concerns (including depression and

to Mr. Farrington, the patient community understands that early detection, screening, and prevention are high priorities that need to be addressed to achieve equity in cancer care, but disparities during the treatment phase are another concern

analysis . Biol Blood Marrow Transplant 2004 ; 10 : 58 – 64 . 101. Nichols WG Gooley T Boeckh M . Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred

overcoming health inequities. The Alliance members used 4 key evidence-based strategies to improve enrollment of people who have been underserved by quality cancer care in their programs: nurse and lay navigators, community-based participatory approaches

to cancer care that is multispecialty, multisite, and has multiple therapeutic options. In the midst of this changing landscape, members of the patient community are voicing concerns about the lack of inclusion and patient-centricity in the cancer